ARDX
|
Ardelyx, Inc.
|
0.05%
|
US
|
NASDAQ
|
ABCM
|
Abcam plc
|
0.05%
|
US
|
NASDAQ
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
0.04%
|
US
|
NASDAQ
|
TSVT
|
2seventy bio, Inc.
|
0.04%
|
US
|
NASDAQ
|
TARS
|
Tarsus Pharmaceuticals, Inc.
|
0.04%
|
US
|
NASDAQ
|
NSTG
|
NanoString Technologies, Inc.
|
0.04%
|
US
|
NASDAQ
|
NKTR
|
Nektar Therapeutics
|
0.04%
|
US
|
NASDAQ
|
LXRX
|
Lexicon Pharmaceuticals, Inc.
|
0.04%
|
US
|
NASDAQ
|
ERAS
|
Erasca, Inc
|
0.04%
|
US
|
NASDAQ
|
EOLS
|
Evolus, Inc.
|
0.04%
|
US
|
NASDAQ
|
EGRX
|
Eagle Pharmaceuticals, Inc.
|
0.04%
|
US
|
NASDAQ
|
CRBU
|
Caribou Biosciences, Inc.
|
0.04%
|
US
|
NASDAQ
|
CDXS
|
Codexis, Inc.
|
0.04%
|
US
|
NASDAQ
|
AVDL
|
Avadel Pharmaceuticals plc
|
0.04%
|
US
|
NASDAQ
|
ARCT
|
Arcturus Therapeutics Ltd.
|
0.04%
|
US
|
NASDAQ
|
ALXO
|
ALX Oncology Holdings Inc.
|
0.04%
|
US
|
NASDAQ
|
ALVR
|
AlloVir, Inc.
|
0.04%
|
US
|
NASDAQ
|
WVE
|
WAVE Life Sciences Ltd.
|
0.04%
|
US
|
NASDAQ
|
NGM
|
NGM Biopharmaceuticals, Inc.
|
0.04%
|
US
|
NASDAQ
|
KZR
|
Kezar Life Sciences, Inc.
|
0.04%
|
US
|
NASDAQ
|